Financhill
Sell
24

CLSK Quote, Financials, Valuation and Earnings

Last price:
$6.71
Seasonality move :
3.03%
Day range:
$6.59 - $6.93
52-week range:
$6.59 - $21.39
Dividend yield:
0%
P/E ratio:
61.00x
P/S ratio:
3.53x
P/B ratio:
0.93x
Volume:
19M
Avg. volume:
25.5M
1-year change:
-68.36%
Market cap:
$1.9B
Revenue:
$379M
EPS (TTM):
$0.11

Earnings Data

Next earnings date for CLSK
May 09
2025
Most recent earnings per share
$0.83
Beat by $0.99
(Feb 6/2025)
Consensus Estimate
-$0.16
(Feb 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CLSK Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $228.3M -- -- $0.11 --
05/09/2025 Q1 $197.5M -- -- $0.07 --
02/06/2025 Q4 $156.4M $162.3M $0.83 -$0.16 $0.99
12/02/2024 Q3 $88.6M $89.3M -$0.27 -$0.16 -$0.11
08/09/2024 Q2 $111.3M $104.1M -$1.03 -- --
05/09/2024 Q1 $109.5M $111.8M $0.58 $0.09 $0.50
02/08/2024 Q4 $69.7M $73.8M $0.14 -$0.26 $0.40
11/30/2023 Q3 $53.7M $51.8M -$0.63 -$0.13 -$0.50
08/09/2023 Q2 $45.7M $45.4M -$0.12 -$0.14 $0.02
05/10/2023 Q1 $41.8M $42.5M -$0.23 -$0.21 -$0.02
02/09/2023 Q4 -- $27.3M -$0.44 -- --
12/14/2022 Q3 -- $24.1M -$0.98 -- --
08/09/2022 Q2 -- $25.8M -$0.71 -- --
05/10/2022 Q1 -- $37.2M -- -- --
02/09/2022 Q4 -- $37.1M $0.35 -- --
12/14/2021 Q3 -- $22M -$0.15 -- --
08/16/2021 Q2 -- $9.1M -$0.49 -- --
05/07/2021 Q1 -- $8.1M $0.22 -- --
02/12/2021 Q4 -- $2.3M -$0.32 -- --
12/17/2020 Q3 -- $2M -$0.41 -- --
08/04/2020 Q2 -- $3.4M -$0.77 -- --
05/11/2020 Q1 -- $3.7M -$1.13 -- --
02/10/2020 Q4 -- $976.8K -$0.40 -- --
09/30/2019 Q3 -- $2.3M -$2.80 -- --
06/30/2019 Q2 -- $1.2M -$0.90 -- --
03/31/2019 Q1 -- $723.9K -$1.88 -- --
12/31/2018 Q4 -- $262.9K -$0.63 -- --
09/30/2018 Q3 -- $111.7K -$11.12 -- --
06/30/2018 Q2 -- $328.6K -$1.80 -- --
03/31/2018 Q1 -- $120.3K -$0.30 -- --
12/31/2017 Q4 -- $18.1K -$0.30 -- --
09/30/2017 Q3 -- $59.4K -$3.10 -- --
06/30/2017 Q2 -- $103.9K -$0.40 -- --
03/31/2017 Q1 -- $200.8K -$0.40 -- --
12/31/2016 Q4 -- $83.9K -$0.30 -- --
09/30/2016 Q3 -- $82K -$0.90 -- --
06/30/2016 Q2 -- -- -$0.10 -- --
03/31/2016 Q1 -- -- -$0.10 -- --
12/31/2015 Q4 -- -- -$0.04 -- --
09/30/2015 Q3 -- -- -$0.02 -- --
06/30/2015 Q2 -- -- -$0.03 -- --

Cleanspark Earnings Questions

  • How Much did Cleanspark Generate in Revenue Last Quarter?

    Cleanspark reported $162.3M worth of top line sales in its most recent quarter.

  • Did Cleanspark Beat Earnings Last Quarter?

    Cleanspark announced earnings per share of $0.83 which represents a beat of analyst forecast a -$0.16 per share.

  • Is Cleanspark Profitable?

    Cleanspark reported $71.1M that represents $0.24 per share over the last quarter.

  • What is the Analyst Consensus for Cleanspark EPS Next Year?

    Cleanspark's earnings are forecast to decrease from -$0.69 per share to $0.53 per share next year representing a decrease of -47.02%.

  • When is Cleanspark's Earnings Date?

    Cleanspark's next earnings date is May 9, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Could IBIT Go?
How High Could IBIT Go?

Recently, a surprising number of billionaire hedge fund managers have…

Is Raymond James Stock a Buy, Sell or Hold?
Is Raymond James Stock a Buy, Sell or Hold?

Raymond James Financial (NYSE:RJF) is one of America’s large financial…

Is JHX Stock a Buy Sell or Hold?
Is JHX Stock a Buy Sell or Hold?

James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
41
Is NVDA Stock a Buy?

Market Cap: $2.6T
P/E Ratio: 37x

Alerts

Buy
80
CORT alert for Apr 1

Corcept Therapeutics [CORT] is up 109.21% over the past day.

Sell
47
RGC alert for Apr 1

Regencell Bioscience Holdings [RGC] is up 26.1% over the past day.

Buy
74
COOP alert for Apr 1

Mr. Cooper Group [COOP] is up 14.4% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock